11/13
04:12 pm
eq
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates [Yahoo! Finance]
High
Report
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates [Yahoo! Finance]
11/13
04:01 pm
eq
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
High
Report
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
11/13
08:00 am
eq
Equillium to Present at the Stifel Healthcare Conference
Medium
Report
Equillium to Present at the Stifel Healthcare Conference
11/12
11:02 am
eq
Opus Genetics, Inc. (IRD) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Opus Genetics, Inc. (IRD) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/12
08:00 am
eq
Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
High
Report
Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
11/6
11:24 am
eq
Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth [Yahoo! Finance]
Low
Report
Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth [Yahoo! Finance]
10/7
08:00 am
eq
Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
High
Report
Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
9/22
12:39 am
eq
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Medium
Report
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
9/17
12:22 pm
eq
Equillium collaborates with Vivtex for oral formulation of autoimmune therapy [Yahoo! Finance]
Low
Report
Equillium collaborates with Vivtex for oral formulation of autoimmune therapy [Yahoo! Finance]
9/10
08:00 am
eq
Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
Low
Report
Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
9/4
08:00 am
eq
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
8/28
08:00 am
eq
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
Low
Report
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference